MIST logo

Milestone Pharmaceuticals Inc.

MIST
Healthcare|Biotechnology|CA
$0.76
+0.07 (+10.15%)
DCF Value
$0.15
Tangible Book / Share
$0.13
Cash / Share
$1.23
Next Earnings Report
Nov 13, 2026
EPS est. -$0.20 · Revenue est. $1.0M
Financing Filings (last 12 months)
1
Shelf registrations / offering prospectuses — latest May 13, 2026 (S-3). Possible dilution.

Upcoming Data Readouts (2)

Jun 2027
Est. completion
P2Paroxysmal Supraventricular Tachycardia
The NODE-202 Study (Study of Etripamil Nasal Spray in Pediatric Patients)
NCT05763953n=60
Dec 2028
Est. completion
P3Atrial Fibrillation
ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3
NCT06716021n=750

Recent Press Releases

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 3, 2026 · GlobeNewsWire
Milestone Pharmaceuticals to Announce Third Quarter 2026 Financial Results on November 13, 2026
Nov 3, 2026 · GlobeNewsWire
New Data Presented at AHA Scientific Sessions 2026 Demonstrate That CARDAMYST® (etripamil) Nasal Spray Converted Recurrent PSVT to Normal Heart Rhythm in Patients with Prior Catheter Ablation
Nov 2, 2026 · GlobeNewsWire
Milestone Pharmaceuticals Announces Clinical Data Presentations at Upcoming Cardiology Conferences
Oct 19, 2026 · GlobeNewsWire
Milestone Pharmaceuticals Announces First European Study Participant Enrolled in ReVeRA-301 Phase 3 Clinical Trial
Oct 9, 2026 · GlobeNewsWire
Milestone Pharmaceuticals Enrolls First Canadian Study Participant in ReVeRA-301 Phase 3 Pivotal Trial Evaluating Etripamil Nasal Spray for AFib-RVR
Sep 24, 2026 · GlobeNewsWire
Milestone Pharmaceuticals Announces NMPA Approval of Etripamil Nasal Spray for PSVT in China, Marking First Regulatory Approval of Etripamil Outside of the United States
Sep 3, 2026 · GlobeNewsWire
Milestone Pharmaceuticals to Present at Upcoming Investor Conferences
Sep 2, 2026 · GlobeNewsWire
Milestone Pharmaceuticals Announces Data Presented at ESC Congress 2026 on the Impact of Paroxysmal Supraventricular Tachycardia (PSVT) on Patients' Daily Lives and Quality of Life Between Episodes
Aug 27, 2026 · GlobeNewsWire
Milestone Pharmaceuticals Initiates Pivotal Phase 3 Trial of Etripamil Nasal Spray for Self-Administered Treatment of Atrial Fibrillation with Rapid Ventricular Rate (AFib-RVR)
Aug 21, 2026 · GlobeNewsWire

SEC Filings (60)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 28, 20268-KMaterial eventDocumentIndex
Sep 3, 20268-KMaterial eventDocumentIndex
Aug 12, 20268-KMaterial eventDocumentIndex
Aug 12, 202610-QQuarterly reportDocumentIndex
Aug 7, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jun 15, 20268-KMaterial eventDocumentIndex
May 22, 2026EFFECTDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 13, 2026S-3Shelf registrationDocumentIndex
May 13, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 13, 20268-KMaterial eventDocumentIndex
May 13, 202610-QQuarterly reportDocumentIndex
Apr 30, 2026ARSAnnual report to holdersDocumentIndex
Apr 30, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 30, 2026DEF 14AProxy / shareholder voteDocumentIndex
Mar 26, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Mar 20, 20268-KMaterial eventDocumentIndex
Mar 20, 202610-KAnnual reportDocumentIndex
Jan 26, 20268-KMaterial eventDocumentIndex
Jan 13, 20268-KMaterial eventDocumentIndex
Jan 6, 20268-KMaterial eventDocumentIndex
Dec 23, 2025SC 13GPassive 5%+ stakeDocumentIndex
Dec 15, 20258-KMaterial eventDocumentIndex
Nov 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Nov 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Nov 13, 2025SC 13GPassive 5%+ stakeDocumentIndex
Nov 12, 20258-KMaterial eventDocumentIndex
Nov 12, 202510-QQuarterly reportDocumentIndex
Aug 12, 2025S-8Employee stock planDocumentIndex
Aug 12, 20258-KMaterial eventDocumentIndex
Aug 12, 202510-QQuarterly reportDocumentIndex
Jul 21, 2025SC 13GPassive 5%+ stakeDocumentIndex
Jul 14, 20258-KMaterial eventDocumentIndex
Jul 14, 2025424B5Offering prospectusDocumentIndex
Jul 11, 2025424B5Offering prospectusDocumentIndex
Jul 11, 20258-KMaterial eventDocumentIndex
Jun 16, 20258-KMaterial eventDocumentIndex
Jun 12, 20258-KMaterial eventDocumentIndex
May 14, 20258-KMaterial eventDocumentIndex
May 14, 202510-QQuarterly reportDocumentIndex